Revised SPC: Biktarvy 50 mg/200 mg/25 mg (bictegravir/emtricitabine/tenofovir) film-coated tablets
Various sections of the SPC have been updated with week 144 safety and efficacy data from the two naïve studies (GS-US-380-1489 and GS-US-380-1490).
Source:
electronic Medicines compendium